Used in research settings as a selective agonist for the EP4 receptor subtype of prostaglandin E2, L755507 helps investigate signaling pathways related to inflammation, immune modulation, and bone metabolism. It is particularly valuable in studies exploring cardiovascular function and potential therapeutic targets for conditions involving dysregulated prostaglandin activity. Due to its specificity, it aids in distinguishing EP4-mediated effects from those of other prostaglandin receptors in cellular and animal models.